Biomedical revitalization plan is not put around the "fever" - Biomedical - Pharmaceutical industries

According to information from the National Development and Reform Commission, the state biomedical industry is expected to revitalize the planning completed for 2-3 months work. In countries with policy-oriented plans to release before, no time to wait for some provinces and cities already starting gun for the country. It is understood that this proposed plan, led by the National Development and Reform Commission, Ministry of Industry, Ministry of Finance, Ministry of Science and other ministries involved in the formulation.

Biomedical "fever"

Yesterday (May 5), industry analyst Lee his (her real name) told the Southern Metropolis Daily reporter said: "look back at the 2009 world's top ten pharmaceutical mergers and acquisitions, we know that our bio-pharmaceutical development, it is possible only to transport ammunition and supplies giants only. "securities of another researcher also holds the same view with his view that" the amount of output is a measure of some local governments struggle with foreign giants an important indicator of foreign biological system drug giant, but in the interest of new product development and marketing in China at every step. " However, individual experts

this "bad-mouth" comment, does not prevent the development of Chinese bio-pharmaceutical high-speed growth momentum. Data show that in 2008 China's output of 866.6 billion yuan to achieve biomedical, bio-pharmaceuticals grew 30.65%. Total economic output last year, biopharmaceutical, or more than 1 trillion.

Biomedicine is a national and local government "core strategies in emerging industries," the behavior of the industry to start heating. According to data in decision-making panoramic terminal data, bio-pharmaceutical industry this year, large capital and large super funds reached 7.707 billion yuan total inflow; only in April, there are 5.0 billion of institutional money into the plate. Release of funds from a quarterly perspective, a total of 38 fund companies are heavy in the first quarter of biopharmaceuticals.

Policy Research Office of the State Development and Reform Commission warned Lee Park China: From a national perspective focused on the development of industry and ultimately, biomedical industry, but in different parts of the right to choose to meet the region's strategic new industries.

Around the "live"

It is understood, Jiangsu, Shanghai, Beijing, Sichuan, Guangdong, Chongqing and other governments are implementing these new industry plan:

Sichuan Sichuan Province has listed bio-pharmaceutical, "12 5" plan sprint athletes in one of the output. Chengdu has introduced a plan to develop the "strive to Chengdu in 2012 biomedical industry economy reached a total 90 billion yuan, sales revenue reached 80 billion yuan of corporate objectives."

Jiangsu biomedical industry's current annual output of about 200 billion yuan, the total size of about 11.5% of the country. Among them, the industrial enzyme, recombinant human insulin, genetically engineered endostatin and other leading drugs in the country. Jiangsu want to biopharmaceutical sales revenue in 2012 more than 500 billion yuan, "the world's biomedical innovation and industrialization of one of the most active."

Beijing Biomedical Engineering by the end of April start, short-listed companies will enjoy a full range of policy support, including public financing, mergers and acquisitions as well as access to credit. Beijing the next 3 years and strive to treat the biotechnology industry from the current size of less than 400 billion yuan to 100 billion yuan.

The end of 2012, Shanghai plans to initially build innovative products of domestic manufacture of bio-medicine center, business center and R & D centers??? Biological pharmaceutical industry reached 200 billion yuan of economic aggregate.

Chongqing will invest in the next three years, "one hundred million yuan to build a strategic emerging biopharmaceutical industry", and strive to add value over 30 billion yuan.

Biopharmaceutical development momentum in Guangdong Province and other provinces are not bad, only the 2010 output is expected to reach Shenzhen, biomedical 100 000 000 000.

Medical Transcription Turnaround Time How to Save Money and Get Benefits on your Prescription Drugs Accurate Medical Peer Review Services Timely And Focused Medical Chart Review Services Concept of Mizaj in Unani system of medicine Revised Info - Stop Your Acid Reflux Suffering Thanks To These Alternative Remedies That Are Drug Free Premature Ejaculation Remedies - 10 Premature Ejaculation Remedies Without Drugs? Concierge Medicine Review - Shared Physician Appointments Drug Side Effects and Seizures At a Scottsdale Medical Spa Separation Of Active Ingredients From Traditional Chinese Medicine The Latest - Extraction - Plan For Treating ADHD Naturally Without Prescription Drugs How Do You Find a Doctor: Tips for Finding the Right Medical Practitioner

Biomedical revitalization plan is not put around the "fever" - Biomedical - Pharmaceutical industries